Two Healthcare Stocks for Beginner Investors with a 30-Year Horizon

  two-healthcare-stocks-for-beginner-investors-with-a-30-year-horizon.html
  Stocks and Investing on Sun, Nov 23rd, 2025 by The Motley Fool
      Locale: UNITED STATES

Two Healthcare Stocks for Beginner Investors with a 30‑Year Horizon

For those just starting out in the world of investing, the idea of picking a single stock can feel daunting. Even more intimidating is the thought of holding a position for decades. Yet, the health‑care sector is a classic “long‑term play” for good reason: it tends to be resilient, it offers both growth and income, and it’s anchored by the universal need for medical services. A recent feature on MSN Money (released November 2025) distilled that wisdom into a concise recommendation for two standout companies—Johnson & Johnson (J&J) and UnitedHealth Group (UNH). The article argues that these names are especially well‑suited to beginners who are comfortable with a 30‑year investment horizon.

Why Healthcare? A Defensive Sector With Built‑In Growth

The author opens by laying out the case for healthcare. Unlike cyclical sectors that suffer in downturns, health‑care businesses are “necessities” that customers will still need even in recessions. This defensive characteristic translates into a more stable earnings stream. Coupled with that is the sector’s intrinsic growth driver: an aging global population, rising chronic‑disease prevalence, and relentless medical‑innovation pipelines. In short, healthcare is a combination of a “must‑have” and a “future‑growth” basket.

The article references the World Health Organization’s projections that the world’s population over 60 will hit 2 billion by 2050, underlining the long‑term supply‑side pressure that will keep the sector expanding. It also cites a recent Morgan Stanley study that estimates healthcare spending will rise from $8.8 trillion in 2023 to $12.9 trillion by 2030—an almost 47 % jump.

Introducing the Pick: Johnson & Johnson

Johnson & Johnson is the poster child of a “well‑diversified” health‑care giant. The company operates in three business segments:

1. Pharmaceuticals – including blockbuster drugs such as Stelara (psoriasis) and Xarelto (anticoagulant).
2. Medical Devices – covering everything from orthopedic implants to surgical instruments.
3. Consumer Health Products – ranging from Band-Aids to Tylenol.

Because of this breadth, J&J is less sensitive to any single product’s success or failure. The article notes that the company’s 2024 fiscal year saw a 4.4 % growth in sales, and it continues to be the world’s largest drugmaker by revenue.

Why It’s Beginner‑Friendly

• Dividend Aristocrat – J&J has increased its dividend for 59 consecutive years, a record that signals reliable cash flow.
• Low Volatility – Its beta is around 0.78, meaning it tends to move less than the broader market.
• Strong Balance Sheet – Cash reserves exceed $15 billion, giving it room to weather short‑term turbulence.

The article quotes a recent J&J earnings call, where the CEO emphasized continued investment in its “growth platform” of rare‑disease therapeutics—a segment that’s already yielded a 10 % YoY revenue lift.

Introducing the Pick: UnitedHealth Group

UnitedHealth Group is the world’s largest health‑care insurer, with a business model that blends premium‑based coverage and data‑driven care management. Its two main subsidiaries are:

1. UnitedHealthcare – offering commercial, Medicare Advantage, and Medicaid plans.
2. Optum – providing data analytics, pharmacy services, and health‑care technology.

The article stresses that UnitedHealth’s Optum arm gives it a competitive edge in the rapidly evolving health‑tech space—a crucial advantage as the industry moves from siloed providers to integrated ecosystems.

Why It’s Beginner‑Friendly

• Robust Earnings Growth – UnitedHealth posted a 12.3 % YoY increase in earnings per share (EPS) in 2023.
• High Return on Equity (ROE) – At 15 %, the company outperforms many peers.
• Defensive Pay‑for‑Use Model – The company’s fee‑for‑service structure provides stable revenue even when overall health‑care spending slows.

A highlighted statistic in the article: UnitedHealth’s share price has outperformed the S&P 500 by 48 % over the past decade, underscoring its potential for a 30‑year gain.

The 30‑Year Horizon: Why Time is Your Best Ally

The article’s core thesis is that with a 30‑year investment horizon, beginners can ride out the inevitable cycles of the market, while benefitting from the compounding of both capital gains and dividends. It illustrates this by simulating a $10,000 investment in each stock:

• Johnson & Johnson – A 30‑year compound growth rate of 8.5 % would turn the investment into roughly $72,000.
• UnitedHealth Group – A 30‑year growth rate of 9.2 % would result in about $87,000.

These estimates take into account dividend reinvestment and a modest inflation assumption of 2 %. The author cautions that these are illustrative figures—not guarantees—and that the real world can deviate. Nonetheless, the point stands: a long timeline dramatically dampens the impact of volatility.

Practical Tips for Beginner Investors

The piece ends with a set of actionable guidelines:

1. Start Small, Add Regularly – Dollar‑cost averaging over time reduces the risk of timing the market.
2. Reinvest Dividends – Both J&J and UNH pay healthy dividends; reinvesting them accelerates growth.
3. Monitor Fundamental Health – Keep an eye on earnings growth, free‑cash‑flow, and debt levels.
4. Diversify Within the Sector – Consider adding a third health‑care name (e.g., Pfizer or Gilead) to spread risk.
5. Stay Informed – Follow company earnings calls and industry reports; the MSN Money article itself links to a “Top 10 Healthcare Stocks to Watch” guide for further reading.

The article also points readers toward a Bloomberg piece on “Healthcare as a Hedge Against Inflation,” providing additional context on how medical spending often rises faster than the broader economy.

Bottom Line

MSN Money’s feature on “2 Healthcare Stocks for Beginner Investors with a 30‑Year Time Horizon” offers a clear, data‑backed roadmap for those looking to harness the stability and growth potential of the health‑care sector. By focusing on well‑diversified juggernauts—Johnson & Johnson and UnitedHealth Group—beginners can confidently set their sights on a long‑term horizon, knowing that these companies have the financial muscle, market breadth, and proven dividend track records to help them weather storms and ride the waves of a rapidly changing world.